Type 1 Diabetes TrialNet Study

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment. Read More

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D. Read More

Middle Tennessee’s latest celebrities are the 11-and-12-year-old Little League U.S. World Series Champions from Goodlettesville. But one young player already had quite a fan base built up at a Vanderbilt pediatric diabetes clinic, where he has been a patient most of his life. Luke Brown and his family are also… Read More

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old. Read More

Research participant Loren Kirkpatrick, right, has worked with Janie Lipps, MSN, and Vanderbilt’s Diabetes Control and Complications Trial since its inception in 1983. (Daniel Dubois / Vanderbilt) Loren Kirkpatrick has been enrolled in the Diabetes Control and Complications Trial (DCCT) at Vanderbilt’s Diabetes Center for nearly half… Read More

Vanderbilt leads the nation in a breakthrough drug study that may prevent type-1 diabetes! Plus, how studying the brain could impact criminal law. And a special tribute on the anniversary of 9/11. [vucastblurb]… Read More

Video: Watch this story about a breakthrough drug study that may prevent type-1 diabetes. Read More

A new study is using technology to achieve better control of blood sugar levels early in the the course of type 1 diabetes. Read More